Spirapril — CAS 83647-97-6

Spirapril is an angiotensin-converting enzyme (ACE) inhibitor used in the treatment of hypertension and heart failure. It works by blocking the conversion of angiotensin I to angiotensin II, thereby reducing blood pressure and decreasing cardiac workload. Mediocon Inc manufactures GMP-compliant Spirapril API at its Aurangabad facility.

• Hypertension management
• Heart failure treatment
• Renal protective therapy
• Cardiovascular risk reduction

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support